Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for PT20 in subjects with hyperphosphataemia requiring dialysis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Dialysis-dependent Chronic Kidney Disease
• Hyperphosphataemia

Drugs mentioned

• PT20

Snippet

Sponsor: Phosphate Therapeutics | Conditions: Hyperphosphataemia | Phase 2 | Status: COMPLETED | Results posted: 2018-01-16